drug
as of 2026-07-01GSK729327
at a glance
small molecule
Pre-approval / investigational in the US
Developed by GlaxoSmithKline
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Evaluation of Single and Repeat Doses of GSK729327 in Healthy Volunteers
NCT00448890Phase 1Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
indication
indication
indication